Posts tagged: Age-related disease

Translating research into drugs for neurodegenerative diseases

- 0 Comments

Millions of people around the world suffer from neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis and Huntington’s disease. Neurodegenerative diseases primarily affect an older population, and as we continue to live longer, incidences of these are expected to soar. Finding treatments and cures for neurodegenerative diseases is therefore a goal of increasing urgency.

Advancing the development of new drugs for neurodegenerative diseases is the target for scientists brought together at the 7th Annual Drug Discovery for Neurodegeneration Conference, hosted by the Alzheimer’s Drug Discovery Foundation (ADDF).

ADDF is a public charity supporting the advancement of drugs to prevent, treat, and cure Alzheimer’s disease, related dementias, and cognitive aging.

On 10-12 February 2013, academic …

Read more

‘Traumatic Brain Injury’ – special series call for submissions

- 0 Comments

Alzheimer’s Research & Therapy is now accepting research submissions for consideration in a special series on traumatic brain injury, planned for publication in spring 2013.

Submit your paper to this series and receive a 50% article processing charge discount – simply quote ‘alzrt-TBI-50’ at submission.

Chronic Traumatic Encephalopathy (CTE) is a progressive degenerative disease of the brain found in people with a history of repetitive brain trauma. This condition has emerged as a significant public health problem, particularly among those in the military or athletes involved in contact sports such as boxing and football.

Despite the growth in media attention and cultural awareness of this condition, the science of CTE is still in its infancy.

Initially …

Read more

‘Cognitive enhancers for ageing and Alzheimer’s disease’ – special series call for submissions

- 0 Comments

Alzheimer’s Research & Therapy is now accepting research submissions for a special series on cognitive enhancers for ageing and Alzheimer’s disease.

Submit your manuscript to this series and receive a 50% article processing charge discount – simply quote ‘alzrtcog50’ at submission.

Cognitive aging affects all of us. In the past few decades, there have been significant advances in our understanding of cognitive aging, but little advance in translating this knowledge into therapeutics. We welcome manuscripts that present new approaches to drug discovery and development for therapeutics to treat cognitive aging.

The publication of these articles in 2013 will be co-ordinated with a series of commissioned reviews and opinions, guest edited by Dr Howard Fillit (ADDF) …

Read more

Longevity & Healthspan – a new journal from BioMed Central

- 0 Comments

In the past, a significant worry for parents was the childhood diseases that would affect or even kill their children. However, investment in microbial, immunological and pharmaceutical research has enabled cures and preventions for many of these diseases. Nowadays, the worry for parents is less for the diseases that could affect their children, but more for the diseases that will affect their own parents.

Longevity & Healthspan is a new journal from BioMed Central that published its first articles today. The journal welcomes research on all aspects of aging biology in the context of healthy aging or age-related disease. In the launch editorial, the Editors-in-Chief; James Kirkland, Gordon Lithgow and Janet Lord, expand upon the idea of the …

Read more